JPMorgan Earnings Preview: Rising Uncertainty Created by

New Post Public Reply Private Reply Replies (1) Message Board
Bible Feed Stock Buff #4

JPMorgan Earnings Preview: Rising Uncertainty Created by Criminal Enterprise


JPMorgan reports QE June 2012 financial results on Friday, July 13, before market open

Last quarter, I reluctantly  gave the devil his due and stated CEO Jamie Dimon and accomplices had not only rebounded big-time in Q1 2012 but the financial deterioration had halted. Then Dimon, now in close competition with Goldman Sachs CEO Lloyd Blankfein and Barclays CEO Robert Diamond as the World’s Most Hated and Corrupt Banker, proves the rot at the top had permeated downwards in the organization chart. The now famous London Whale et al. trading losses have been estimated at $2 billion to $9 billion.

Numerous other regulatory investigations are underway regarding the illicit activities at this $2+ trillion American taxpayer-guaranteed criminal enterprise. Even the Federal Energy Regulatory Commission (FERC) is looking into energy price-fixing which defrauded consumers! I did caution last quarter, “Just remember, as you have read in many financial disclaimers, past performance is not a predictor or indicator of future performance”. I normally don’t say this but had obvious wariness, disdain, and distrust of Dimon. Little did I realize at the time that Dimon Criminal Enterprises was so pervasive at JPMorgan Chase & Co.

The banking business is a component, but not all of JPMorgan, no matter how much management talks about banking. About 30% of total assets are net loans and 36% are trading assets and investment securities. Cash, cash equivalents, securities, and trading assets combined are 60% of total assets. Ultimately that leaves 10% in non-earning assets such as goodwill and buildings.

Standard Jamie Dimon Criminal Enterprises Disclosure and Warning: Keep in mind when trading JPM stock, you are trading their traders for a portion of the quarterly earnings per share lotto. Additional risk includes the efficiency and stealth of the ongoing criminal operations. Improper risk management (trading losses) plus insufficient lobbying of and contributions to (bribing) of politicians could adversely affect financial performance and JPM stock price.

Even if a worst-case scenario trading loss upwards to $9 billion should be realized, this is still financially manageable. Total equity at 3-31-12 was $189 billion with a capital ratio of 8.18%. Deduct the entire $9 billion and the capital ratio is still an adequate 7.79%. Solvency is not an immediate concern although the capital ratio needs to stay above 7%.

At 3-31-12, I had rated JPMorgan a “D” on a scale of A+ to G-. The median rating is “D” and the average rating was “C”. Financial position strength is weighted more than financial performance. The bank ratings review is here .

For Q2 2012, analysts’ EPS estimates are in a wide range which reflects the uncertainty about JPM. Earnings per share projections are a -20% to -86% drop QoQ and a -17% to -85% drop YoY. The average is -40% QoQ and -38% YoY. Be prepared for a wild ride.

Estimated QE June 2012 Earnings per Share
Yahoo Finance Estimates: $0.79 avg, $0.19 low, $1.05 high, 29 analysts
Prior Quarter: $1.31
Prior Year: $1.27
Outlook: none provided

Prior Quarterly Review: JPMorgan Earnings Rebound to Near-Record Levels, Deterioration Halted

JPMorgan Income Statement Q1 2012 Financial performance significantly improved QoQ, was flat YoY, and is respectable. Net Revenues were a very strong $26.71 billion, Net Income was a near-record $5.38 billion, and Earnings Per Share was a multi-year, if not all-time, high of $1.31. For QoQ, these were +24%, +44%, and +46%, respectively. For YoY, these were +6%, -3%, and +2%, respectively. Both the Operating Margin of 29% and Net Margin of 20% popped to 3-quarter highs. The operating expense ratio of 62% increased QoQ and YoY to a multi-year, if not all-time, high and is almost out of control.

JPMorgan Balance Sheet Q1 2012 JPMorgan’s “fortress balance sheet” is now $2.32  trillion in total assets. Overall financial position is adequate and stable, that is, not much change QoQ and YoY. The capital ratio of 8.18% is lower than desirable, but adequate, as are the Tier 1 Capital and Tier 1 Common ratios. Return on assets is a respectable +0.83%.

I nominate CEO Jamie Dimon’s statement in the earnings press release as some of the greatest fascist propaganda ever written: “JPMorgan Chase positively impacts the lives of millions of people and the communities in which they live. We are serving them each day, putting our resources and our voices to work on their behalf”. This would be second place, only to Goldman Sachs CEO Lloyd Blankfein saying, “I’m doing God’s work”.

Largest USA Banks Ratings: Capital One & U.S. Bancorp Tops, Goldman Sachs Last

JPMorgan Earnings Rebound to Near-Record Levels, Deterioration Halted

$ JPM $ XLF

J P Morgan Chase & Co (JPM) Stock Research Links

JPM Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

King Risk Partners Expands Mid-Atlantic Presence Boldly

Updated Category News Views 1

King Risk Partners Grows with New Jersey Acquisition You don't get far in the insurance game without making some bold moves, and King Risk Partners just made a big one—sweeping into New Jersey. They've snagged Conover Beyer Associates Insurance, a firm that's been around longer than some European countries. It's not every day you buy a piece of history, but that's...

Continue Reading
Innovative SOV Launches for Offshore Wind Revolution

Updated Category News Views 1

A New Era for Offshore Wind Operations Mark my words, folks, this launch ain't just some minor milestone swaying gently on the industry seas. ZPMC's 'Wind of Ocean' is about to kickstart a whole new game in Europe's offshore wind space. Built with brains and brawn, this vessel embodies the future of sustainable and efficient offshore operations. The announcement from...

Continue Reading
TCL's Energy Vision Unveiled at IFA 2026

Updated Category News Views 0

TCL's Forward-Thinking Approach at IFA 2026 IFA 2026 in Berlin got a jolt when TCL Industries and TCL Technology rolled out their ambitious plans under the banner "Inspiration Habitat." By blending cutting-edge smart devices with clean energy advancements, TCL is frantically waving red flags for anyone with an eye on future living trends. The Heartbeat of Inspiration...

Continue Reading
UGREEN's MagFlow Series: A Game-Changer in Charging

Updated Category News Views 1

UGREEN Unveils a Cool Revolution in Charging Out in Foxborough, UGREEN is shaking things up at its Smart Living Launch Event. The big reveal? The MagFlow Series, their flagship wireless charging lineup, which promises faster and cooler charging than ever before. UGREEN's taking wireless charging to new heights, and that's got my attention. What Makes MagFlow Stand Out...

Continue Reading
LG Electronics Unveils Smart Home Innovations at IFA

Updated Category News Views 0

Alright, let's dive into this world of shiny new gadgets that LG Electronics has trotted out at the IFA 2026. As European homes get cozier, folks aren't just after any appliance—they're seeking ones that blend smarts, efficiency, and style. So, LG's rolling out seven of their latest and supposedly greatest home appliances, hoping they'll hit the mark with the modern...

Continue Reading
Charity's Bold Move: Acquiring Wayfinder for K-12 Impact

Updated Category News Views 1

Public Charity Expands Into Education Well, here's something that's bound to turn a few heads: a fast-growing public charity has just made its first acquisition in the K-12 sphere by snapping up Wayfinder. The stakes are getting interesting. When a charity starts playing in the acquisition space, you're looking at a change in strategy that deserves close attention. Why...

Continue Reading
Armed Security: Balancing Safety with Cost in Rochester

Updated Category News Views 3

The Decision to Arm: When Business Risks Demand It You know, deciding whether to hire armed security isn't as clear-cut as some folks make it seem. It ain't just about slapping a guard at your door. There's a whole set of chess moves behind it, especially in good ol' Rochester. When you're juggling high-risk operations, like handling valuable inventory or dealing with...

Continue Reading
Curaleaf Expands in Florida Amid Rising Cannabis Demand

Updated Category News Views 1

Curaleaf's Bold Moves in Florida's Ganja Gold Rush Fresh out of the gate, Curaleaf is saddling up for a wild ride into Florida's cannabis frontier. They've just thrown open the doors of their latest dispensary in Riverview, cranking their statewide count up to 77. Now, isn’t that something? If you're tracking these folks, you know that bringing their nationwide total to...

Continue Reading
IVD Study Success: Hybrid Monitoring Boosts Oversight

Updated Category News Views 1

New Strategies for IVD Clinical Studies It's high time we addressed the tangled web of managing in vitro diagnostic (IVD) clinical studies. We're talking about walking a tightrope where sponsors have to juggle regulatory scrutiny, data integrity, and operational efficiency—all while pushing innovation. Simply put, the old ways of doing things just aren't cutting it...

Continue Reading
Flex Acquires EPC Power in a $4.4 Billion Deal

Updated Category News Views 2

An Acquisition with Enormous Implications Folks, if you haven't been paying attention, you're missing out on a seismic shift. EPC Power's sale to Flex for a hefty $4.4 billion isn't just another transaction; it's a clear signal of where the future's headed, especially if you're plugged into the energy or tech sectors. With the way AI is guzzling power like a thirsty...

Continue Reading

Top 5 Most Recently Viewed Articles

BioCardia's Innovative Therapy Shows Promise in Cardiac Care

Updated Category News Views 197

BioCardia Unveils Promising Results in CardiAMP Cell Therapy BioCardia, Inc. (NASDAQ: BCDA), a pioneer in cell therapy for cardiovascular conditions, recently shared the groundbreaking results from its CardiAMP trial. This innovative cellular therapy targets chronic myocardial ischemia, a serious health issue impacting many individuals due to reduced blood flow to the...

Continue Reading
The Pharmacovigilance Software Market Set for Growth with AI Innovations

Updated Category News Views 165

Growth of the Pharmacovigilance Software Market The global pharmacovigilance and drug safety software market is set to experience remarkable growth, projecting an increase of USD 69.1 million over the forecast period running from 2024 to 2028. A key factor influencing this expansion is the rising rates of adverse drug events, which have prompted healthcare and...

Continue Reading
Quaker Houghton's Remarkable Q3 Revenue Growth Unveiled

Updated Category News Views 143

Quaker Houghton Reports Strong Financial Performance for Q3 Quaker Houghton, recognized as a leading provider of industrial process fluids, demonstrated solid performance in its third quarter results. The company's net sales reached an impressive $493.8 million, marking a notable increase of 7% compared to the prior year. This growth was driven by an organic sales volume...

Continue Reading
Nerivio® REN Wearable Gains Wider Medicaid Coverage in US

Updated Category News Views 87

Nerivio® REN wearable made waves when it gained wider Medicaid coverage back in 2024, opening up significant avenues for migraine treatment across several states like Arizona, New Jersey, Ohio, and Virginia. The buzz was palpable on the trading floor as this initiative could potentially bring affordable migraine relief to seven million more people. You know how these...

Continue Reading
Strengthening Leadership: Augustine Therapeutics Appoints Key Roles

Updated Category News Views 279

Enhancing Leadership at Augustine Therapeutics Augustine Therapeutics recently announced a significant enhancement to its management team, with the appointments of Virginie Cartage as Chief Financial Officer (CFO) and Dr. Andy Hu as Chief Business Officer (CBO). These strategic additions come at a pivotal moment as the company advances its lead program, AGT-100216, into...

Continue Reading